0EH logo

Toleranzia DB:0EH Stock Report

Last Price

€0.037

Market Cap

€13.9m

7D

7.6%

1Y

57.8%

Updated

22 Dec, 2024

Data

Company Financials

0EH Stock Overview

A biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases. More details

0EH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Toleranzia AB Competitors

Price History & Performance

Summary of share price highs, lows and changes for Toleranzia
Historical stock prices
Current Share PriceSEK 0.037
52 Week HighSEK 0.047
52 Week LowSEK 0.013
Beta1.36
1 Month Change26.21%
3 Month Change38.64%
1 Year Change57.76%
3 Year Change-64.81%
5 Year Changen/a
Change since IPO-73.22%

Recent News & Updates

Recent updates

Shareholder Returns

0EHDE BiotechsDE Market
7D7.6%-2.9%-2.6%
1Y57.8%-14.7%6.9%

Return vs Industry: 0EH exceeded the German Biotechs industry which returned -14.7% over the past year.

Return vs Market: 0EH exceeded the German Market which returned 6.9% over the past year.

Price Volatility

Is 0EH's price volatile compared to industry and market?
0EH volatility
0EH Average Weekly Movement22.0%
Biotechs Industry Average Movement6.8%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 0EH's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 0EH's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
201111Charlotte Fribertwww.toleranzia.se

Toleranzia AB, a biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases. The company is primarily developing TOL2 drug candidate for treating myasthenia gravis, an autoimmune nerve and muscle disease. The company also develops TOL3 drug candidate to treat ANCA vasculitis, an autoimmune blood vessel disease.

Toleranzia AB Fundamentals Summary

How do Toleranzia's earnings and revenue compare to its market cap?
0EH fundamental statistics
Market cap€13.90m
Earnings (TTM)-€619.11k
Revenue (TTM)€3.06m

4.5x

P/S Ratio

-22.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0EH income statement (TTM)
RevenueSEK 35.16m
Cost of RevenueSEK 35.91m
Gross Profit-SEK 754.00k
Other ExpensesSEK 6.37m
Earnings-SEK 7.12m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 21, 2025

Earnings per share (EPS)-0.026
Gross Margin-2.14%
Net Profit Margin-20.26%
Debt/Equity Ratio5.1%

How did 0EH perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:09
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Toleranzia AB is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution